跳至主要内容
临床试验/CTRI/2019/10/021592
CTRI/2019/10/021592招募中不适用

Clinical Evaluation of Lohasava and Amalaki Churna in the management of Iron Deficiency Anemia (Pandu)

Central Council For Research In Ayurvedic Sciences2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年10月30日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
2
主要终点
Change in Hemoglobin percentage

研究概览

简要总结

The nearest correlationof Pandu Roga can be made with iron deficiency anemia (IDA) in Modernsystem of medicine. Iron deficiency anemia arises when the balance of ironintake, iron stores and the body’s loss of iron are insufficient to fullysupport production of erythrocytes. As the IDA is a very common prevalentdisease in the society and the side effects of oral modern ironpreparations are very common, therefore to get a better alternative, anAyurvedic herbomineral medicine,  Lohasava and Amalaki Churna, was chosen for a clinical trial in patients suffering from IDA.

Lohasava is a fermentedformulation that contains lauha churna processed with some herbs as triphala,trikatu etc. Iron is absorbed more easily in its ferrous form and ferrous ironsare formed in the acid conditions of gastric contents. Hence the formulationslike Amalaki Churna helps to develop that media which can improve the ironabsorption at gastric level and also acts as a carminative which reduces themal- metabolism of food and body tissues. Amalaki is also known for itsrasayana karma.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • (i)Hb 8gm-10gm.% (ii)S.Ferritin <13 µg/L(female) or <30 µg/L(male) (iii)TIBC level >450mcg/dL (iv)S.Iron<60μg/dL for male;<50 for female (v)MCV level<80fL/red cell (vi)RDW >46fL (vii)Reticulocyte count <0.5% (Among these the first 3 are the essential criteria for inclusion)
  • Willing and able to participate for 112 days.

排除标准

  • 1.Iron deficiency likely or definitely due to blood loss from the intestine or other sites.
  • 2.History or evidence of intestinal malabsorption 3.Major co-morbidity such as a serious chronic medical condition unrelated to iron deficiency apparent on history, physical examination or laboratory tests 4.Other causes of anemia (sickle cell disease, thalassemia,other hemolytic anemia, bone marrow failure, etc.) apparent by history, physical examination, and/or laboratory tests 5.Liver enzymes, AST/ALT > 2 x the upper limit;serum creatinine more than the upper limit.
  • 6.Patients on prolonged (> 6 weeks) medication that may have an influence on the outcome of the study 7.Other medical or social factors at discretion of treating physician.

结局指标

主要结局

Change in Hemoglobin percentage

时间窗: Baseline, and 84th day

次要结局

  • Change in Serum ferritin level(Change in Serum iron level)

研究者

申办方类型
Other [Autonomous research organisation under Ministry of AYUSH, Govt. of India ]

研究点 (2)

Loading locations...

相似试验